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Phenobarbital induces liver cytochrome P-450 b,e 
proteins mainly by increasing the rate of transcription 
of these genes. The mechanism responsible for the phe- 
nobarbital increment in the rate of transcription of cy- 
tochrome P-450 b,e genes is unknown. The objective of 
this study was to assess whether active protein synthesis 
was needed for phenobarbital to induce the liver cyto- 
chrome P-450 b,e genes. Cycloheximide (2 mg per kg, 
i.p.) was administered 90 min prior to a single inductive 
dose of phenobarbital (80 mg per kg, i.p.) and mRNAS 
measured at 3, 6 and 12 hr by dot-blot hybridization. 
While phenobarbital increased cytochrome P-450 b,e 
mRNAs about 12-fold at 3 hr, this induction was abol- 
ished by cycloheximide. To define whether the absence 
of protein synthesis in hepatocytes inhibited the pheno- 
barbital induction of cytochrome P-450 at the transcrip- 
tional level, in uitro transcription rates using isolated 
nuclei were measured. After phenobarbital administra- 
tion, there was about a 20-fold increment in transcrip- 
tional rate of cytochrome P-450 b,e genes. This incre- 
ment was abolished by prior injection of cycloheximide. 
It is proposed that either preexisting regulatory proteins 
or transacting factors dependent on active protein syn- 
thesis participate in the regulation of liver cytochrome 
P-450 b,e gene transcription after phenobarbital. 
Phenobarbital (PB) exerts several inductive effects on 
hepatocytes. Among them, the induction of various forms 
of cytochrome P-450 have elicited considerable interest 
(1). The molecular mechanism responsible for the induc- 
tion of cytochrome P-450 b,e genes by PB, the two main 
components of the PB-inducible cytochrome P-450 fam- 
ily (l), has been defined as an increased rate of transcrip- 
tion of these genes in response to PB (2, 3). However, 
the induction of cytochrome P-450 proteins in response 
t o  PB occurs only in some hepatocytes. These hepato- 
cytes are located in the distal half of the liver acinus 
(Zones 2 and 3), the microvascular unit of hepatic paren- 
chyma (4-6). This heterogeneous induction of cyto- 
chrome P-450 proteins indicated that another intraaci- 
nar level of regulation in the expression of these P-450 
genes must occur. Moreover, recent studies using either 
isolated hepatocytes (7) or in situ hybridization (8 )  have 
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shown that the levels of cytochrome P-450 b,e mRNAs 
were induced predominantly in hepatocytes of Zones 3 
and 2 of the liver acinus, respectively. However, the 
various intracellular events responsible for the increment 
in transcription rates of cytochrome P-450 b,e genes in 
response to PB have not been defined. 
In this study, the objective was to determine whether 
active protein synthesis in hepatocytes was necessary for 
PB to induce cytochrome P-450 b,e genes. Because cy- 
cloheximide inhibited the PB-mediated induction of cy- 
tochrome P-450 b,e mRNAs in these experiments, as 
well as the PB increment in transcription rates in nuclear 
run-off studies, we propose that protein synthesis is 
required for the PB-mediated induction of these genes. 
MATERIALS AND METHODS 
Induction of Cytochrome P-450 b,e Genes 
Effect of Cycloheximide on the P B  Induction of Cytochrome 
P-450 b,e mRNAs: Nonfasted Sprague-Dawley male rats 
weighing between 180 and 220 gm were used in all of these 
experiments. Cycloheximide (Sigma Chemical Co., St. Louis, 
Mo.) was freshly prepared by dissolving it in 0.15 M NaCl and 
injected as a single dose of 2 mg per kg (i.p.). Four groups of 
three animals each were studied. (a) Controls were injected 
with 0.15 M NaC1. (b) PB-treated rats were injected with PB 
(80 mg per kg, i.p.) and livers removed after 3, 6 and 12 hr. (c) 
Cycloheximide-PB-treated rats received cycloheximide (2 mg 
per kg, i.p.) followed 90 min later by PB. This experimental 
design assured that PB was injected at the time of maximal 
inhibition of protein synthesis by this dose of cycloheximide 
(9). Livers were removed at  3,6 and 12 hr after PB administra- 
tion. (d) Cycloheximide-treated rats received 2 mg per kg (i.p.) 
of cycloheximide only. Livers were removed after 3, 6 and 12 
hr. 
The NIH Guidelines for the care and treatment of laboratory 
animals were followed in this study. 
Quantitation of Cytochrome P-450 b,e mRNAs 
Livers were frozen in liquid nitrogen 
and stored at  -70°C. for 1 to 2 weeks prior to RNA extraction. 
Preliminary studies showed that under these conditions, there 
is no loss of RNA nor is there significant degradation as 
assessed by Northern-blot analysis. RNA was extracted from 
livers of each group of animals according to Chirgwin et al. 
(10). Only samples with a 260/280 absorbance ratio above 1.8 
were used. 
Northern Blots: The size of the mRNA hybridizing to cy- 
tochrome P-450 b,e cDNA probes was assessed by Northern- 
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blot analysis, as previously described (7). Ten micrograms of 
total RNA were loaded into 1% agarose gels containing 2.2 M 
formaldehyde and electrophoresis performed at 5 V per cm for 
4 hr. Formaldehyde-denatured RNA was transferred into nitro- 
cellulose filters, and the filters air-dried and baked for 2 hr at 
80°C under vacuum. Nitrocellulose filters were prehybridized 
for 2 hr a t  65°C in a solution containing: (a) 6 X  standard 
sodium citrate (0.9 M sodium chloride and 0.1 M sodium 
citrate); (b) 0.5% sodium dodecyl sulfate; (c) 5x Denhardt’s 
solution (1% Ficoll, 1% polyvinylpyrrolidone and 1% bovine 
serum albumin), and (d) 100 pg per ml of denatured salmon 
sperm DNA. 
Hybridization was performed at  65°C for 16 hr in a solution 
containing 0.9 M sodium chloride, 0.1 M sodium citrate, 0.5% 
sodium dodecyl sulfate, 5 x  Denhardt’s solution, 0.01 M EDTA, 
100 pg per ml of denatured salmon sperm DNA and 25 ng per 
ml of [~i-~~P]-labeled cDNA insert (see next section). Filters 
were washed (7) and autoradiography performed at  -70°C using 
Kodak X-Omat AR film between two intensifying screens. 
Quantitatiue Dot-Blot Hybridization: The method used was 
a modification of that of Papavasiliou et al. (11). A Minifold I1 
system and nitrocellulose filters were used in these measure- 
ments. In this assay, the concentration of the cytochrome P- 
450 b,e cDNA probes was always in excess. Each RNA sample 
was spotted in concentrations of 0.25, 0.5, 0.75, 1.0, 1.5 and 2.0 
pg per spot. This approach allowed the assessment of the 
linearity of the measurements with each sample. An internal 
standard, also spotted in six concentrations, was always in- 
cluded in each new filter to assess the reproducibility of the 
spotting and blotting procedure as well as the efficiency of 
hybridization. This internal standard consisted of RNA ex- 
tracted from a PB-treated liver and stored at  -70°C. The 
quality of this RNA serving as a standard was assessed period- 
ically by Northern-blot analysis and quantitated by dot-blot 
hybridization as described here. This allowed the comparison 
of the slopes of the lines obtained with each filter. After 
hybridization, the filters were washed (7), autoradiography 
performed and 32P-~pm in each spot counted. For this purpose, 
the nitrocellulose paper was cut-off in each spot while back- 
ground radioactivity was assessed by counting a cut-off of 
nitrocellulose paper in which RNA had not been spotted. Non- 
specific hybridization was assessed by spotting pBR322. Results 
have been expressed as cpm bound per microgram of RNA (11). 
Preparation of the cDNA Probe: The cytochrome P-450 b,e 
probe used in these experiments was a generous gift from Dr. 
M. Adesnik (New York University). This clone (R17) consists 
of a 1,100 b.p. cDNA cloned into pBR322. This cDNA codes 
for 211 amino acids of the 3’-carboxyterminal end of a poly- 
peptide corresponding to cytochrome P-450 e (12). Due to the 
extensive homology between cytochrome P-450 b,e genes (13), 
this cDNA recognizes sequences of both cytochrome P-450 b,e 
mRNAs. In this study, the measured levels of cytochrome P- 
450 mRNA have been expressed as if both cytochromes were 
assessed simultaneously. Accordingly, measurements have been 
described in the text as “cytochrome P-450 b,e mRNAs.” 
The cDNA was isolated from R17 by agarose gel electropho- 
resis and electroblotting onto DEAE membranes (Schleicher 
and Schuell, Keene, NH) and was labeled with [32P]dATP 
(Amersham Corp., Arlington Heights, Ill.; 3,000 Ci per mmole) 
by the “oligolabeling” method [large fragment (Klenow) of 
DNA polymerase I, BRL, Gaithersburg, Md.] of Feinberg and 
Vogelstein (14). 
To assess the specificity of the effects of cycloheximide on 
cytochrome P-450 genes, levels of albumin mRNA were deter- 
mined using the same RNA samples in which cytochrome P- 
450 mRNA measurements were performed. Thus, albumin 
mRNA levels were assessed in control, PB-treated and cyclo- 
heximide-PB-treated rats. These measurements were per- 
formed as previously described, except that the cDNA probe 
used was pmalb 2, a generous gift from Drs. S. Tilghman and 
Belayew (15). The cDNA insert was isolated and labeled with 
[32P]dATP by the oligolabeling method (14). 
In Vitro Transcription Rates: Nuclear Run-Off Assay 
Animal Preparation: Male Sprague-Dawley rats weighing 
180 to 200 gm were used in these experiments. Four groups of 
four animals each were studied (a) controls (C), who were 
injected with 0.15 M NaCl, i.p.; (b) PB-treated rats received 80 
mg per kg (i.p.) PB and were studied 3 hr later; (c) cyclohex- 
imide-treated rats received 2 mg per kg (i.p.) and experiments 
were performed 3 hr later, and (d) cycloheximide-PB-treated 
rats received 2 mg per kg (i.p.) cycloheximide followed 90 min 
later by 80 mg per kg (i.p.) PB. Experiments were performed 3 
hr after PB injection. 
Preparation of Isolated Nuclei: Nuclei were isolated accord- 
ing to Schibler et al. (16) with few modifications. Livers were 
homogenized in 20 volumes 0.3 M sucrose in buffer A [60 mM 
KCl, 15 mM NaC1, 0.15 mM spermin, 0.5 mM spermidine, 14 
m M  P-mercaptoethanol, 0.5 mM EGTA, 2 mM EDTA, 15 mM 
Hepes (pH 7.5)]. The homogenate was filtered through nylon 
cloth (mesh width = 100 pm), layered over a 10 ml cushion of 
30% sucrose in buffer A and spun for 10 min at 2,500 rpm in a 
SS 34 rotor (Sorvall). Crude nuclei were resuspended in 42 ml 
2 M sucrose in buffer B (prepared as buffer A except, that 0.1 
mM EGTA and 0.1 mM EDTA were used) and centrifuged at 
36,000 rpm for 30 min at 4°C in an SW 41 rotor (Beckman L2- 
65B centrifuge). The clean nuclei were sedimented in nuclei 
storage buffer [20 mM Tris-HC1 (pH 7.9), 75 mM NaC1, 0.5 
mM Na2EDTA, 0.85 mM dithiothreitol, 50% (v:v) glycerol]. 
The nuclear pellet was resuspended in nuclei storage buffer at  
a concentration of 106 nuclei per p1 of nuclei storage buffer. 
Nuclei were stored a t  -70°C for 24 hr before use. 
I n  Vitro Transcription Assay: The transcription reaction 
was performed according to Love et al. (17). The transcription 
reaction was initiated by adding 3 X 10’ nuclei (300 pl) to 300 
pl of the transcription assay solution [ATP, GTP, CTP, 1 mM 
each; 4.4 mM magnesium acetate, 1.7 m M  MnClZ, 7.15 m M  
Tris (pH 8.0); 1.43 M KC1; 500 pCi [ c ~ - ~ ~ P ] U T P  (400 Ci per 
mmole; Amersham Corp.)]. The final concentration of [ ( Y - ~ ~ P ]  
UTP in the reaction was 2.08 pM.  The assay was performed at  
23°C for 30 min. The reaction was terminated by addition of 4 
M guanidinium thiocyanate solution [50 m M  sodium citrate, 
130 mM 6-mercaptoethanol, 2% sarcosyl, 10 mM EDTA (pH 
8.0)]. The RNA transcripts were purified in a CsClz gradient 
according to Love et  al. (17). 
Assessment of Transcripts: The elongation of nascent RNA 
chains or transcripts was measured by hybridization of the 
[32P]RNA transcripts generated in the transcription reaction 
to nylon membranes (NytranO, Schleicher and Schuell) con- 
taining the cytochrome P-450 cDNA probe. In these experi- 
ments, the cytochrome P-450 b,e cDNA was isolated from the 
R17 clone as previously described and cloned into the pGem-1 
riboprobe. Northern-blot analysis (not shown here) showed 
that this pGem-1 containing the cytochrome P-450 cDNA 
hybridized to a mRNA of identical size as that hybridized by 
the cDNA insert (shown in Figure 1). The pGem-1-cytochrome 
P-450 b,e cDNA plasmid was linearized (HindIII), denatured 
in 0.5 N NaOH:1.5 M NaCl and 100 ng (concentration deter- 
mined by measuring the 260 nm absorbance) blotted onto nylon 
membranes using a Minifold I1 apparatus. The method of 
hybridization used was that of Church and Gilbert (18). Hy- 
bridization was performed at  65°C for 18 hr. Each hybridization 
was performed using 4 ml hybridization buffer, a 6.2 x 2.8 cm 
nylon membrane and 1 x lo7 cpm per ml. At the end of the 
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1 shows that, by Northern-blot analysis, the ["Plcyto- 
chrome P-450 cDNA probe used in these experiments 
hybridized to a mRNA of about 2.1 kb. This corresponds 
to the size of mRNAs previously reported for cyto- 
chromes P-450 b,e mRNAs (1). Figure 2a shows the 
results of the quantitative dot-blot analysis. The auto- 
radiography corresponding only to the samples obtained 
FIG. 1. Northern-blot analysis of cytochrome P-450 b,e mRNAs. (Lane 
1 ) Control; 10 pg RNA loaded. (Lane 2) PB-induced RNA extracted 
16 hr after a single dose of PB (80 mg per kg, i.p.); 10 pg RNA loaded. 
(Lane 3) A-size markers (Hind11 digest). 
hybridization, the filters were washed (18) and autoradiography 
performed. Background hybridization was assessed by using 
pGem-1 plasmid without the cDNA insert. 
RESULTS 
The effect of blocking protein synthesis at the trans- 
lational level by cycloheximide on the increments in 
cytochromes P-450 b,e mRNAs by PB was studied. In 
these experiments, cycloheximide was injected (2 mg per 
kg, i.p.) followed 90 min later by the administration of 
PB (80 mg per kg, i.p.). It should be noted that maximal 
inhibition of protein synthesis (by at  least 80%) has been 
observed with this dose of cycloheximide (9, 19). Figure 
FIG. 2. Cytochrome P-450 b,e mRNAs. Effect of cycloheximide. (a) 
Dot-blot analysis. Controls = injected with 0.15 M NaCI; PB = PB- 
treated (80 mg per kg, i.p.); Cx-PB = cycloheximide (2 mg per kg, i.p.) 
followed 90 min later by PB (80 mg per kg, i.p.); Cx = cycloheximide 
(2 mg per kg, i.p.). Numbers a t  the right-hand side of the abbreviation 
for each group indicate the time interval (in hours) between the 
injection and the removal of the liver. In Cx-PB, it indicates time after 
PB administration. At  the bottom, the amount of RNA spotted in each 
slot is indicated. Each sample was analyzed in six different concentra- 
tions. The raw data obtained after 6 hr are not shown. (b) The same 
data calculated as cpm DNA bound per microgram of RNA spotted. 
Mean & S.E. of three animals per group. Livers were removed after 3, 
6 and 12 hr of the PB injection. Dotted bars = cytochrome P-450 b,e 
mRNAs after PB administration. Solid bars = cytochrome P-450 b,e 
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at 3 and 12 hr is shown. An entirely similar resolution 
was obtained with all samples analyzed. Quantitation of 
dot-blots is presented in Figure 2b. In this figure, results 
have been expressed as cpm per microgram of RNA 
spotted. When PB was injected alone, the levels of cy- 
tochrome P-450 b,e mRNAs increased about 10-fold at  3 
hr and about 30-fold by 12 hr. Cycloheximide injected 90 
min before PB administration abolished the induction of 
the cytochrome P-450 b,e mRNAs. Cycloheximide was 
injected alone in two experiments, and RNA was ex- 
tracted at 3,6 and 12 hr. The levels of cytochrome P-450 
b,e mRNAs were low (results not shown) and apparently 
lower than in controls. However, given the low levels of 
expression of the cytochrome P-450 b,e genes in controls, 
it became apparent that many more experiments would 
be needed to ascertain whether the constitutive expres- 
sion of these genes was influenced by cycloheximide. 
This was not the purpose of these studies. To assess the 
specificity of these results, the effects of cycloheximide 
on the levels of albumin mRNA were determined using 
the same RNA in which cytochrome P-450 was measured. 
Figure 3 shows that albumin mRNA levels were not 
influenced by cycloheximide administration at the time 
intervals studied. 
To assess whether this inhibitory effect of cyclohex- 
imide on cytochrome P-450 b,e induction by PB was 
exerted at  the level of the transcription of these genes, 
in vitro transcription assays were performed. Figure 4 
shows the autoradiography of a representative experi- 
ment involving the measurements of in uitro transcrip- 
tion in each of the four groups (control, cycloheximide, 
cycloheximide-PB and PB alone). The hybridization sig- 
nals of controls and after cycloheximide alone were faint. 
In contrast, 3 hr after the administration of PB, there 
was about a 20-fold increment in the rate of in uitro 
transcription of the cytochrome P-450 b,e genes. Cyclo- 
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FIG. 3. Effect of cycloheximide on albumin mRNA levels. Albumin 
mRNA levels were assessed using the same RNA samples obtained 
from controls, PB-treated and cycloheximide-PB-treated rats described 
in Figure 2 (a and b). The albumin cDNA insert was isolated and 
labeled with [s2P]dATP by the oligolabeling method (14). Dotted bars 
= albumin mRNA after PB administration. Solid bars = albumin 
mRNA after PB preceded, 90 min earlier, by the administration of 
cycloheximide. Mean * S.E. of three animals per group except the 
point at 12 hr in which only two samples were measured. 
induced increment in the rate of in vitro transcription. 
A total of five experiments measuring in uitro transcrip- 
tion in each of the four groups studied were performed. 
All experiments showed similar results. Cycloheximide 
always blocked the induction of cytochrome P-450 b,e 
genes by PB. 
DISCUSSION 
The aim of this study was to determine whether active 
protein synthesis in hepatocytes was required for the 
induction of cytochrome P-450 b,e genes in response to 
PB. This represents an initial approach to elucidate the 
molecular mechanisms leading to the transcriptional in- 
duction of these genes. 
Cycloheximide has been used in several studies in an 
attempt to answer whether the rate of protein synthesis 
influences the expression or the induction of genes (19- 
23). The possibility that cycloheximide may indiscrimi- 
nately depress gene activity by decreasing RNA poly- 
merase I1 is unlikely. Following cycloheximide adminis- 
tration, measurements of RNA polymerase I1 activity 
have indicated that the activity of this enzyme is in- 
creased (20). Moreover, induction of certain genes to 
levels higher than those observed with the inducer alone 
or “superinduction” has been reported after cyclohex- 
imide administration (21). Such an example is the su- 
perinduction of cytochrome P,-450 (representative of a 
different family of P-450 than P-450 b or e) in the 
presence of cycloheximide and the inducer 2,3,7,8-te- 
trachlorodibenzo-p-dioxin in mouse hepatoma cells (21). 
Under these conditions, the induction of the P,-450 gene 
is 10-fold higher than in the presence of the inducer 
alone. Therefore, the effect of cycloheximide on gene 
expression appears to be selective and, accordingly, the 
regulation of genes can be separated into those dependent 
on, or independent of, protein synthesis (19, 22-23). 
Moreover, similar responses of genes have been observed 
when other agents blocking protein synthesis at a trans- 
lational level, such as emetine, have been used (19). 
These observations suggest that, in these experiments, 
cycloheximide was acting in its capacity to inhibit pro- 
tein synthesis rather than in a nonspecific manner. 
In this study, PB was injected in viuo at the time of 
maximal inhibition of protein synthesis by cycloheximide 
(9, 19). Cycloheximide blocked the induction of cyto- 
chrome P-450 b,e mRNAs by PB. In contrast, the levels 
of albumin mRNA were not affected within the time 
interval of these experiments. The mechanism of this 
apparent difference in the response of cytochrome P-450 
b,e genes and of the albumin gene to cycloheximide needs 
further study. 
The nuclear run-off studies indicated that the molec- 
ular mechanism responsible for the inhibition of the PB- 
mediated induction of cytochromes P-450 b,e genes is 
the inability of PB to increase the transcription rates of 
these genes in the absence of active protein synthesis in 
hepatocytes. These observations suggest that a pro- 
tein(s), either present at  the time of PB administration 
or synthesized in response to PB, modulates the induc- 
tion of the cytochrome P-450 b,e genes by activating (or 
derepressing) the rate of transcription of these genes. If 
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FIG. 4. In vitro transcription assay of cytochrome P-450 b,e genes 
using isolated liver nuclei. Controls, cycloheximide (Cx), PB and Cx- 
PB groups were prepared as described in the legend to Fig. 2. In these 
experiments, nuclei were isolated 3 hr after injections (in Cx-PB, 3 hr 
after PB administration). RNA transcripts generated in each transcrip- 
tion assay were hybridized against duplicate blots containing 100 ng 
pGem-1 cytochrome P-450 cDNA insert isolated from R17. This is one 
representative sample of five individual experiments in each group. In 
each experiment, cycloheximide blocked almost completely the incre- 
ment in transcription observed after PB. The mean difference in 
transcription signals between PB and Cx-PB assessed by densitometric 
analysis was 11-fold. This autoradiography was exposed for 72 hr. 
the regulatory protein is preexisting in the cytoplasm or 
nucleus of hepatocytes, it must have a relatively short 
half-life to account for the observed results. Therefore? 
we propose that transacting regulatory proteins partici- 
pate in the modulation of the rate of transcription of the 
liver cytochrome P-450 b,e genes in response to PB 
administration. 
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